Manipulating the Gut Microbiome to Alleviate Steatotic Liver Disease: Current Progress and Challenges
-
Published:2024-09
Issue:
Volume:40
Page:51-60
-
ISSN:2095-8099
-
Container-title:Engineering
-
language:en
-
Short-container-title:Engineering
Author:
Saenz Ernesto, Montagut Nathally Espinosa, Wang Baohong, Stein-Thöringer Christoph, Wang Kaicen, Weng Honglei, Ebert Matthias, Schneider Kai Markus, Li Lanjuan, Teufel AndreasORCID
Reference154 articles.
1. Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016 2. Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al.; NAFLD Nomenclature Consensus Group. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol 2023;79(6):1542–56. 3. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis;Ye;Lancet Gastroenterol Hepatol,2020 4. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030;Estes;J Hepatol,2018 5. Nonalcoholic fatty liver disease: from steatosis to cirrhosis;Farrell;Hepatology,2006
|
|